{"id":4406,"date":"2025-12-31T13:58:57","date_gmt":"2025-12-31T13:58:57","guid":{"rendered":"https:\/\/www.lifeviz.com\/publication\/tratamento-de-lesoes-cutaneas-desfigurantes-na-neurofibromatose-1-com-everolimus-um-ensaio-de-fase-ii-aberto-de-braco-unico-drugs-in-rd-2018\/"},"modified":"2025-12-31T13:58:57","modified_gmt":"2025-12-31T13:58:57","slug":"tratamento-de-lesoes-cutaneas-desfigurantes-na-neurofibromatose-1-com-everolimus-um-ensaio-de-fase-ii-aberto-de-braco-unico-drugs-in-rd-2018","status":"publish","type":"publication","link":"https:\/\/www.lifeviz.com\/pt-pt\/publication\/tratamento-de-lesoes-cutaneas-desfigurantes-na-neurofibromatose-1-com-everolimus-um-ensaio-de-fase-ii-aberto-de-braco-unico-drugs-in-rd-2018\/","title":{"rendered":"Tratamento de les\u00f5es cut\u00e2neas desfigurantes na neurofibromatose\u20111 com everol\u00edmus: um ensaio de fase II, aberto, de bra\u00e7o \u00fanico – Drugs in R&D (2018)"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categoriepublication":[],"class_list":["post-4406","publication","type-publication","status-publish","hentry"],"acf":{"type":"","mise_en_avant":false,"lien":"https:\/\/link.springer.com\/article\/10.1007\/s40268-018-0248-6"},"_links":{"self":[{"href":"https:\/\/www.lifeviz.com\/pt-pt\/wp-json\/wp\/v2\/publication\/4406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifeviz.com\/pt-pt\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.lifeviz.com\/pt-pt\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.lifeviz.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=4406"}],"wp:term":[{"taxonomy":"categoriepublication","embeddable":true,"href":"https:\/\/www.lifeviz.com\/pt-pt\/wp-json\/wp\/v2\/categoriepublication?post=4406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}